Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

glaxosmithkline biologicals s.a. - poliovirus types 1, poliovirus types 3 - suspension oral - not less than-106ccid50/dose+ not less than-105.8ccid50/dose

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

glaxosmithkline biologicals s.a. - poliovirus types 1, poliovirus types 3 - suspension oral - not less than-106ccid50/dose+ not less than-105.8ccid50/dose

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

glaxosmithkline biologicals sa-nv - virus polio type i, strain lsc, 2ab >= 1000000 ccid50/0,1 ml; virus polio type iii, strain leon 12a, 1b >= 600000 ccid50/0,1 ml - oral suspension - poliomyelitis virus - poliomyelitis oral, bivalent, live attenuated

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - virus polio type 1, strain lsc, 2ab; virus polio type 3, strain leon 12a, 1b - suspension - virus polio type 1, strain lsc, 2ab ≥10⁶·˚ccid₅₀; virus polio type 3, strain leon 12a, 1b ≥10⁵·⁸ccid₅₀

Kenya - English - Pharmacy and Poisons Board

serum instititute of india pvt. ltd. 212/2, hadapsar, pune- 411 028, india. - monovalent bulk of poliomyelitis vaccine… - oral solution - each dose of 2 drops (0.1 ml) contains polio… - poliomyelitis oral bivalent live attenuated

Kenya - English - Pharmacy and Poisons Board

glaxosmithkline pharmaceutical kenya limited p.o. box 78392 - 00507, nairobi, kenya - virus polio type 1, strain lsc, 2ab; virus polio… - oral suspension - virus polio type 1, strain lsc, 2ab… - poliomyelitis oral bivalent live attenuated

Kenya - English - Pharmacy and Poisons Board

china sinopharm international corporation… 4, huixindongjie, chaoyang district, beijing - virus strain polio virus seed (sabin strain) type… - oral drops - each dose of 2 drops (0.1ml) contains polio virus… - poliomyelitis oral bivalent live attenuated

Israel - English - Ministry of Health

glaxo smith kline (israel) ltd - poliomyelitis virus type 1; poliomyelitis virus type 1; poliomyelitis virus type 3 - suspension - poliomyelitis virus type 3 nlt 10^6.0 ccid50; poliomyelitis virus type 1 nlt 10^5.8 ccid50; poliomyelitis virus type 1 nlt 10^6.0 ccid50 - poliomyelitis oral, monovalent live attenuated - active immunisation against poliomyelitis infection caused by types 1 and 3 poliomyelitis viruses at any age after receiving at least one dose of ipv.